IDEXX Laboratories (FRA:IX1) Shiller PE Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:IX1 IDEXX Laboratories Inc FRA:IX1
96 GF Score
Price €440.10
GF Value €568.79
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is IDEXX Laboratories Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


IDEXX Laboratories  (FRA:IX1) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


IDEXX Laboratories Shiller PE Ratio Related Terms


IDEXX Laboratories Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for IDEXX Laboratories's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories Shiller PE Ratio Chart

IDEXX Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 166.77 88.99 96.56 64.19 80.56

IDEXX Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.79 75.62 80.05 63.88 58.62

FRA:IX1 vs A, IQV, WAT: Shiller PE Ratio Comparison

For the Diagnostics & Research subindustry, IDEXX Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Shiller PE Ratio falls into.


FRA:IX1
96GF Score
IDEXX Laboratories Inc FRA:IX1
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEXX Laboratories Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

IDEXX Laboratories's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, IDEXX Laboratories's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.6697/333.9520*333.9520
=3.670

Current CPI (Jun. 2026) = 333.9520.

IDEXX Laboratories Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 0.556 241.428 0.768
201612 0.536 241.432 0.742
201703 0.723 243.801 0.990
201706 0.863 244.955 1.177
201709 0.673 246.819 0.911
201712 0.365 246.524 0.494
201803 0.822 249.554 1.100
201806 1.032 251.989 1.368
201809 0.903 252.439 1.194
201812 0.855 251.233 1.136
201903 1.033 254.202 1.357
201906 1.277 256.143 1.665
201909 1.117 256.759 1.452
201912 0.937 256.974 1.218
202003 1.171 258.115 1.515
202006 1.565 257.797 2.028
202009 1.444 260.280 1.853
202012 1.687 260.474 2.163
202103 1.951 264.877 2.460
202106 1.941 271.696 2.385
202109 1.718 274.310 2.092
202112 1.653 278.802 1.980
202203 2.021 287.504 2.347
202206 1.459 296.311 1.645
202209 2.136 296.808 2.403
202212 2.016 296.797 2.268
202303 2.376 301.836 2.629
202306 2.453 305.109 2.685
202309 2.323 307.789 2.520
202312 2.156 306.746 2.347
202403 2.585 312.332 2.764
202406 2.264 314.175 2.407
202409 2.552 315.301 2.703
202412 2.455 315.605 2.598
202503 2.815 319.799 2.939
202506 3.202 322.561 3.315
202509 2.913 324.800 2.995
202512 2.650 324.054 2.730
202603 2.969 330.213 3.003
202606 3.670 333.952 3.670

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is IDEXX Laboratories (FRA:IX1) Overvalued in 2026?

Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued. The current stock price of €440.10 is trading 22.6% below its estimated GF Value™ of €568.79. GuruFocus considers IDEXX Laboratories to be Modestly Undervalued.

Key valuation signals for FRA:IX1:

  • Shiller PE Ratio:
  • GF Value™: €568.79 vs. price of €440.10 (22.6% below fair value)
  • GF Score™: 96/100 with 1 warning sign

No single metric tells the full story. See the FRA:IX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IDEXX Laboratories Business Description

Address One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
96GF Score

Get the complete analysis for FRA:IX1

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€440.10
Price
€568.79
GF Value